CANTEL MEDICAL CORP's ticker is CMD and the CUSIP is 138098108. A total of 294 filers reported holding CANTEL MEDICAL CORP in Q2 2018. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $2,774,041 | -2.0% | 34,745 | -3.2% | 0.03% | -10.3% |
Q4 2020 | $2,830,207 | +67.6% | 35,889 | -6.6% | 0.03% | +52.6% |
Q3 2020 | $1,689,098 | -2.1% | 38,441 | -1.4% | 0.02% | -5.0% |
Q2 2020 | $1,724,528 | +123.4% | 38,990 | +81.3% | 0.02% | +81.8% |
Q1 2020 | $772,101 | -49.4% | 21,507 | 0.0% | 0.01% | -31.2% |
Q4 2019 | $1,524,846 | -4.6% | 21,507 | +0.6% | 0.02% | -11.1% |
Q3 2019 | $1,599,000 | -7.9% | 21,377 | -0.7% | 0.02% | -5.3% |
Q2 2019 | $1,736,018 | +17.3% | 21,528 | -2.7% | 0.02% | +11.8% |
Q1 2019 | $1,480,008 | -10.2% | 22,126 | -0.0% | 0.02% | -19.0% |
Q4 2018 | $1,647,802 | -19.4% | 22,133 | -0.4% | 0.02% | -4.5% |
Q3 2018 | $2,045,297 | -6.7% | 22,217 | -0.3% | 0.02% | -15.4% |
Q2 2018 | $2,192,000 | -48.5% | 22,282 | -41.7% | 0.03% | -48.0% |
Q1 2018 | $4,257,000 | +144.1% | 38,210 | +125.4% | 0.05% | +150.0% |
Q4 2017 | $1,744,000 | – | 16,951 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DIKER MANAGEMENT LLC | 1,805,250 | $61,144,000 | 18.90% |
Brown Capital Management | 4,069,141 | $137,822,000 | 2.95% |
Kimelman & Baird, LLC | 364,514 | $12,346,000 | 2.60% |
Teton Advisors, Inc. | 396,782 | $13,439,000 | 1.18% |
Ranger Investment Management | 565,995 | $19,170,000 | 0.93% |
Geller Advisors LLC | 26,043 | $882,000 | 0.75% |
CONNORS INVESTOR SERVICES INC | 57,826 | $1,959,000 | 0.63% |
Boston Trust Walden Corp | 733,798 | $24,853,000 | 0.40% |
MISSOURI VALLEY PARTNERS, INC. | 24,481 | $829,000 | 0.32% |
GENEVA CAPITAL MANAGEMENT LLC | 451,958 | $15,307,000 | 0.31% |